date:Nov 05, 2012
n of Pfizer Nutrition has been approved in China, the company said. The acquisition is still subject to other closing conditions. We therefore do not make any further comment at this stage.
Bulcke also signaled Nestle could look at further deals.
You have to look at how many opportunities are out there ... We're happy with what may come and we'll embrace that. We're always open to opportunities, he said.
Asked if Nestle could do more deals of the size of the Pfizer unit purchase, Bulcke said: